Call for Collaboration

   To accelerate the validation and clinical application of our candidate gene signatures, we invite research institutions and related companies to collaborate with us on larger-scale validation studies. By partnering with us, you will play a pivotal role in advancing cancer prognosis research and personalized medicine.

   We deeply value the contributions of our research collaborators and are committed to fostering long-term, mutually beneficial relationships. Collaborators will be acknowledged as co-authors on resulting publications and share in future patent royalties. The specific terms of cooperation will be determined through mutual agreement to ensure alignment with your goals and contributions.

   If you possess high-quality breast cancer cohort data or share an interest in our research direction, we warmly invite you to join this important project. For inquiries or to learn more about this collaboration opportunity, please contact us at info@bluewater-biotech.com. We look forward to working together to advance innovative solutions in cancer care.

Partnership Opportunities

   We are actively seeking business partners and investors to support our mission of advancing innovative healthcare solutions. Your involvement can help drive the commercialization of our diagnostic gene signatures, ensuring they reach patients who need them most.

  By partnering with us, you will gain access to a comprehensive business plan that outlines our strategy, market potential, and growth opportunities. Your investment will contribute to shaping the future of precision medicine while offering significant returns as we unlock the full market potential of our technology.

   If you are interested in exploring partnership opportunities, please reach out to us at info@bluewater-biotech.com.